| |
BioMarin Europe Ltd.,
headquartered in London, operates branch offices
in England, Germany, Italy, Spain, Portugal and
Switzerland, serving patients in the 25 member
states of the European Union, Iceland and Norway.
BioMarin Brasil Farmacêutica
in Sao Paulo serves the growing Naglazyme patient
population throughout Latin America.
To discuss potential partnership opportunities
with BioMarin Europe Ltd., please contact our
Business Development group at bd@bmrn.com.
|
|
